These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7217843)

  • 1. A subvertebrate system for rapid determination of potential teratogenic hazards.
    Johnson EM
    J Environ Pathol Toxicol; 1980 Nov; 4(5-6):153-6. PubMed ID: 7217843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tier system for developmental toxicity evaluations based on considerations of exposure and effect relationships.
    Johnson EM
    Teratology; 1987 Jun; 35(3):405-27. PubMed ID: 3307013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro testing for developmental toxicity using the Hydra attenuata assay.
    Wiger R; Støttum A
    NIPH Ann; 1985 Dec; 8(2):43-7. PubMed ID: 2417165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hydra attenuata system for detection of teratogenic hazards.
    Johnson EM; Gorman RM; Gabel BE; George ME
    Teratog Carcinog Mutagen; 1982; 2(3-4):263-76. PubMed ID: 6130626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different embryo-fetal toxicity effects for three VLA-4 antagonists.
    Crofts F; Pino M; DeLise B; Guittin P; Barbellion S; Brunel P; Potdevin S; Bergmann B; Hofmann T; Lerman S; Clark RL
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):55-68. PubMed ID: 15098199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproductive safety studies with genistein in rats.
    McClain RM; Wolz E; Davidovich A; Edwards J; Bausch J
    Food Chem Toxicol; 2007 Aug; 45(8):1319-32. PubMed ID: 17433519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental toxicity study with diethylene glycol dosed by gavage to CD rats and CD-1 mice.
    Ballantyne B; Snellings WM
    Food Chem Toxicol; 2005 Nov; 43(11):1637-46. PubMed ID: 15979775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the acute, chronic and teratogenic effects of a mixture of eleven pharmaceuticals on the cnidarian, Hydra attenuata.
    Quinn B; Gagné F; Blaise C
    Sci Total Environ; 2009 Jan; 407(3):1072-9. PubMed ID: 19013635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.
    Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teratogen update: evaluation of the reproductive and developmental risks of caffeine.
    Christian MS; Brent RL
    Teratology; 2001 Jul; 64(1):51-78. PubMed ID: 11410911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of teratogenic potential of therapeutic agents: preclinical toxicology.
    Frederick GL
    Clin Invest Med; 1985; 8(4):323-7. PubMed ID: 4075617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for teratogenic hazards: nature of the problems.
    Johnson EM
    Annu Rev Pharmacol Toxicol; 1981; 21():417-29. PubMed ID: 7016011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro differential developmental toxicity of vitamin A congeners.
    Johnson EM; Chun YH
    Teratology; 1989 Apr; 39(4):349-61. PubMed ID: 2749578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro tests in screening teratogens: considerations to aid the validation process.
    Kimmel GL
    Prog Clin Biol Res; 1985; 163C():259-63. PubMed ID: 3991628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of developmental toxicity of amitraz in Sprague-Dawley rats.
    Kim JC; Shin JY; Yang YS; Shin DH; Moon CJ; Kim SH; Park SC; Kim YB; Kim HC; Chung MK
    Arch Environ Contam Toxicol; 2007 Jan; 52(1):137-44. PubMed ID: 17083001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental toxicity of mixtures: the water disinfection by-products dichloro-, dibromo- and bromochloro acetic acid in rat embryo culture.
    Andrews JE; Nichols HP; Schmid JE; Mole LM; Hunter ES; Klinefelter GR
    Reprod Toxicol; 2004 Nov; 19(1):111-6. PubMed ID: 15336719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing.
    Webster WS; Brown-Woodman PD; Ritchie HE
    Int J Dev Biol; 1997 Apr; 41(2):329-35. PubMed ID: 9184342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.